is this extensions good and the information is correct?

Question

An additional extension could involve CRISPR-Cas9 to target specific regulatory regions of the genome influence expression multiple genes responsible for treatments for thalassemia

Answer 1

Yes, the information provided in the extension is correct. The use of CRISPR-Cas9 technology to target specific regulatory regions of the genome can indeed influence the expression of multiple genes responsible for treatments for thalassemia. Thalassemia is a genetic disorder characterized by abnormal hemoglobin production, and targeting specific regulatory regions with CRISPR-Cas9 can potentially correct the underlying genetic mutations associated with the condition.